Abeona Therapeutics Inc SMA 200
¿Qué es el SMA 200 de Abeona Therapeutics Inc?
El SMA 200 de Abeona Therapeutics Inc es $6 +0.08%
¿Cuál es la definición de SMA 200?
SMA 200 es un precio promedio de las acciones de los últimos 200 días calculado como una media no ponderada de los previos 200 precios de cierre de acciones.
Simple moving average of 200 days for a stock is an unweighted moving average over the past 200 days. Moving averages will always exhibit a lag and the longer the period used for averaging the greater the lag will be. Because of the large amounts of data considered when calculating a long-term moving average, it takes a considerable amount of movement in the market to cause the moving average to change its course.
Using a moving average to confirm a trend in price is one of the most basic, yet effecting ways of using the indicator. Moving averages take into account what has already happened and a whole range of past events, which makes them such a good technical analysis tool for trend confirmations. Generally, a long-term moving average that is clearly on the upswing is a confirmation of a bullish trend. Conversely, a long-term moving average that is clearly on the downswing is a confirmation of a bearish trend.
SMA 200 de compañías en Sector Health Care en NASDAQ en comparadas con Abeona Therapeutics Inc
¿Qué hace Abeona Therapeutics Inc?
abeona therapeutics inc. (nasdaq: $abeo), is a leading clinical-stage biopharmaceutical company focused on developing novel gene therapies for life-threatening rare genetic diseases. abeona was forged from the company’s close collaborations with key stakeholders all dedicated to transforming new biotechnology insights into breakthrough treatments for rare diseases. abeona's lead programs include abo-102 (aav-sgsh), an adeno-associated virus (aav) based gene therapy for sanfilippo syndrome type a (mps iiia) and eb-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (rdeb). abeona is also developing abo-101 (aav-naglu) for sanfilippo syndrome type b (mps iiib), abo-201 (aav-cln3) gene therapy for juvenile batten disease (jncl), abo-202 (aav-cln1) for treatment of infantile batten disease (incl), eb-201 for epidermolysis bullosa (eb), abo-301 (aav-fancc) for fanconi anemia (fa) disorder and abo-302 using a novel crispr/cas9-based gene editing approach to gene t
Empresas con sma 200 similar a Abeona Therapeutics Inc
- Applied Dna Sciences Inc tiene SMA 200 de $6 -269.28%
- Voya International High Dividend Equity Income Fund tiene SMA 200 de $6 +0.00%
- MDC Partners tiene SMA 200 de $6 -2.95%
- Riskified tiene SMA 200 de $6 -21.88%
- Ferratum Oyj tiene SMA 200 de €6 -12.67%
- Zevra Therapeutics Inc tiene SMA 200 de $6 +3.90%
- Abeona Therapeutics Inc tiene SMA 200 de $6 +0.08%
- Biodelivery Sciences International tiene SMA 200 de $6 +0.00%
- Antares Pharma Inc tiene SMA 200 de $6 +0.00%
- Chesswood tiene SMA 200 de CAD$6 -521.14%
- Lantern Pharma tiene SMA 200 de $6 -50.31%
- Nuveen Credit Strategies Income Fund tiene SMA 200 de $6 +5.37%
- IMP Powers tiene SMA 200 de ₨6 +0.00%